Cutaneous reactions due to Pfizer's BNT162b2 mRNA and Moderna's mRNA-1273 vaccines.

Oulee, A; Salem, S; Yahia, R; Yang, K; Garcia, D; Holmes, A; Furukawa, B

Oulee, A; Salem, S; Yahia, R; Yang, K; Garcia, D; Holmes, A; Furukawa, B.

Oulee A; School of Medicine, University of California, Riverside, CA, USA.
Salem S; School of Medicine, University of California, Riverside, CA, USA.
Yahia R; School of Medicine, University of California, Riverside, CA, USA.
Yang K; School of Medicine, University of California, Riverside, CA, USA.
Garcia D; Department of Internal Medicine, Loma Linda University, Loma Linda, CA, USA.
Holmes A; Department of Dermatology, Loma Linda University, Loma Linda, CA, USA.
Furukawa B; Department of Dermatology, Loma Linda University, Loma Linda, CA, USA.

J Eur Acad Dermatol Venereol ; 36(5): e332-e334, 2022 05.

Article in English | MEDLINE | ID: covidwho-1624575

Subject(s)

2019-nCoV Vaccine mRNA-1273; COVID-19; BNT162 Vaccine; COVID-19/prevention & control; Humans; RNA, Messenger; mRNA Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / 2019-nCoV Vaccine mRNA-1273 Topics: Vaccines Limits: Humans Language: English Journal: J Eur Acad Dermatol Venereol Journal subject: Dermatology / Sexually Transmitted Diseases Year: 2022 Document Type: Article Affiliation country: Jdv.17925

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google